"Dzhakavi" dhigooda (ruksolitinib) qiimaha. Halkee si ay u iibsadaan Dzhakavi jaban

daroogada cusub ee "Dzhakavi" macmalay by shirkadda Swiss "Novartis" ka mid ah takhaatiirta ka daweeyo kansarka caan ah.

Ruksolitinib, qayb weyn ee firfircoon oo sheegay waxaa loola jeedaa - inhibitor tyrosinkinashämmare protein ah. Waa wax ku ool ah in daawaynta cudurada kuwaas oo la xidhiidha splenomegaly, myelofibrosis iyo sidoo (oo ay ku jiraan hoose iyo kuwa sare, kaas oo diyaariyey iyadoo ay sabab u thrombocythemia lagama maarmaanka ah iyo polycythemia).

Cilmibaadhayaasha ayaa la soco isticmaalka daroogada hoos size caajisnimo by 35%, cimri kordhay iyo tayada. Sayidka sumoobo ee qayb firfircoon waa dhexdhexaad ah marka loo eego daroogooyinka kale ee spectrum la mid ah garoomada.

Halka aad kaniiniga "Dzhakavi" iibsan kartaa jaban

Laakiin ka hor inta Socota leh sharaxaad ka mid ah daroogada, ma dhihi karno oo ku saabsan daaweynta cudurro halis ah u baahan yahay wax badan oo ka mid ah daroogada qaali ah, iyo this laakiin ma keeni kartaa walaac ka mid ah bukaanka. Tanaasulaan daawooyinka lagama maarmaanka ah suurtogal ma aha, laakiin sidoo kale si aad u hesho inta badan waa kuwo ku adag. Sayidka, ee iska- ee Moscow on kiniinka "Qiimaha Dzhakavi 'bilaabo 100 000 rubles.

Si badbaadinta ah ee xaaladdaan ku iman kartaa goobta WWW.ONKO24.COM meesha aad ka iibsan kartaa daroogada generic yeedhay. Marka la mid ah waa complete, iyo saameyn la mid ah oo ku saabsan codsiga kici doonto wax badan ka jaban. Xaqiiqada ah in wax soo saarka guud ma dhali kharashka soo koraya, qalabka baaritaanka, iyo kor u qaadida u ogolaanaya saarayaasha hoos ruqsad rasmi ah oo shaqo, dib u bixiso daynta daroogada qiimo jaban.

Qadarka Qaadashada iyo dose diyaarinta

Bukaan-socodka waa in ay ogaadaan in isticmaalka "Dzhakavi" daroogada ka madax bannaan yahay cunto qaadashada. Oo haddii waqtiga qoray loox oo cabitaan ku guuldareystay ah, aadan qaadan karin qaddar laba jibbaar ah iyaga ka mid ah. Waxaa loo baahan yahay ma aha, sababtoo ah ee shaqada iyo soo dhaweynta ee soo socda.

Qiyaasta hore oo ka mid ah waxyaabaha lagu tilmaamay waxaa la qoray oo kaliya by takhasus leh, waxay ku xiran tahay xuduudaha ka dhiig - xinjirowga. Sida caadiga ah, waa 15 mg (p qaadataan 2 maalin kasta.), Ay ka mid yihiin at 100-200 / NL, halka lacagta ah oo ka badan 200 / NL - 20 mg. Haddii tirada platelets waa 50-100 / NL, qiyaasta ugu badan ee hore waa in aan ka badnayn 5 mg laba jeer maalintii. Qiyaasta ugu badan sheegashada LABAGEEDI doonaan in ay daroogada tilmaamaha "Dzhakavi" si loogu isticmaalo waa in aan ka badnayn 25 mg, qaaday laba jeer maalintii.

Guud ahaan, daaweynta waa in la sameeyaa si joogto ah count ruksolitinibom in unugyada dhiiga (erythrocytes, leukocytes iyo platelets) 2-4 toddobaad kasta inta lagu guda jiro doorashada ee qiyaasta, ka dibna, iyada oo ku xiran tilmaamo caafimaad.

sababo

Waayo, isticmaalka daroogada "Dzhakavi" waxaa jira sababo gaar ah:

1. Uurka iyo nuujinta.
2. da'da bukaanka da'doodu ka yar tahay siddeed iyo toban sano jir.
3. dulqaad ruksolitiniba Personal ama qayb kale oo ka mid ah diyaarinta.

Sida lagu qeexay dalabka jawaabaha khubaro "Dzhakavi" ee hadda jira, waxay ka dhigan tahay u baahan tahay in loo isticmaalo si taxadir leh ee lagu daaweeyo bukaanka qaba kelyaha ama kelyaha. In category la mid ah oo ka mid ah bukaanka qaba Torombositobiiniya, neutropenia iyo dhiig la'aan.

waxyeellooyin

In codsiga, sida ka muuqata ku lifaaqan "Dzhakavi" edbinta, inta badan lagu arkay socda dhibaato:

• cudurada kaadi mareenka,
• anemia;
• neutrophils;
• Torombositobiiniya;
• dhiigbax (oo ay ku jiraan nabar, sanka iyo dhiig intracranial iyo hemorrhage ee mareenka caloosha iyo mindhicirka);
• korodh miisaan,
• wareer;
• hypercholesterolemia;
• madax xanuun.